| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/2014 | US8710039 Therapeutic compositions and methods |
| 04/29/2014 | US8710038 Pyrazole kinase modulators and methods of use |
| 04/29/2014 | US8710037 Pyrrolidine derivatives, pharmaceutical compositions containing the same, and methods of using the same |
| 04/29/2014 | US8710036 Carbonate and carbamate modified forms of glucocorticoids in combination with β2 adrenergic agonists |
| 04/29/2014 | US8710035 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer |
| 04/29/2014 | US8710034 Method and composition for improving skin barrier function |
| 04/29/2014 | US8710033 Use of LPA for encouraging pregnancy, and fertility agent |
| 04/29/2014 | US8710032 Inhibitors of the mevalonate pathway of Streptococcus pneumoniae |
| 04/29/2014 | US8710031 Compounds for nonsense suppression and methods for their use |
| 04/29/2014 | US8710030 Phosphonate compounds |
| 04/29/2014 | US8710028 Pharmaceutical powder compositions |
| 04/29/2014 | US8710027 Method of using nutritional compounds dihydroquercetin (taxifolin) and arabinogalactan in combination with dihydroquercetin (taxifolin) to reduce and control cardiometabolic risk factors associated with metabolic syndrome and hypercholesterolemia |
| 04/29/2014 | US8710023 Antisense modulation of C-reactive protein expression |
| 04/29/2014 | US8710021 Inhibition of HRP-3 using modified oligonucleotides |
| 04/29/2014 | US8710020 Clusterin antisense therapy for treatment of cancer |
| 04/29/2014 | US8710019 Topical antibiotic composition for the prevention of Lyme disease |
| 04/29/2014 | US8710018 Methods and compositions for inhibiting progression to chronic cardiac failure |
| 04/29/2014 | US8710015 Tropoelastin derivatives |
| 04/29/2014 | US8710002 Methods of enhancing diabetes resolution |
| 04/29/2014 | US8709996 Pharmaceutical treatment process using chitosan or derivative thereof |
| 04/29/2014 | US8709976 Anthranilic diamide compositions for propagle coating |
| 04/29/2014 | US8709827 Polypeptide microparticles |
| 04/29/2014 | US8709738 Methods for predicting cardiac toxicity |
| 04/29/2014 | US8709515 Nutritional supplement method |
| 04/29/2014 | US8709513 Liquid formulations of carboxamide arthropodicides |
| 04/29/2014 | US8709500 Drug delivery system |
| 04/29/2014 | US8709498 Method of stimulating tissue healing |
| 04/29/2014 | US8709485 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability |
| 04/29/2014 | US8709482 Stabilised prostaglandin composition |
| 04/29/2014 | US8709478 Once daily formulations of tetracyclines |
| 04/29/2014 | US8709477 Pharmaceutical dosage form |
| 04/29/2014 | US8709476 Compositions of quaternary ammonium compounds containing bioavailability enhancers |
| 04/29/2014 | US8709475 Stable pharmaceutical composition and methods of using same |
| 04/29/2014 | US8709474 Liposomes with improved drug retention for treatment of cancer |
| 04/29/2014 | US8709470 Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities |
| 04/29/2014 | US8709466 Cationic polymers for antimicrobial applications and delivery of bioactive materials |
| 04/29/2014 | US8709465 Diazeniumdiolated phosphorylcholine polymers for nitric oxide release |
| 04/29/2014 | US8709463 Hemostatic devices and methods of making same |
| 04/29/2014 | US8709460 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles |
| 04/29/2014 | US8709449 Methods and compositions for improving photodynamic therapy through administration of lipids |
| 04/29/2014 | US8709440 Agent for expelling parasites in humans, animals or birds |
| 04/29/2014 | US8709439 Film-forming resins as a carrier for topical application of pharmacologically active agents |
| 04/29/2014 | US8709431 Enediyne compounds, conjugates thereof, and uses and methods therefor |
| 04/29/2014 | US8709426 Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
| 04/29/2014 | US8709419 Combination therapy |
| 04/29/2014 | US8709409 Method for treating rheumatoid arthritis by administering an anti-IL-6 antibody and methotrexate |
| 04/29/2014 | US8709406 Prevention and treatment of oxidative stress disorders by gluthathione and phase II detoxification enzymes |
| 04/29/2014 | US8709395 Method for repairing or replacing damaged tissue |
| 04/29/2014 | US8709394 Antimicrobial polysiloxane materials containing metal species |
| 04/29/2014 | US8709393 Methods and compositions for wound healing |
| 04/29/2014 | US8709392 Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers |
| 04/29/2014 | US8709391 Family of pain producing substances and methods to produce novel analgesic drugs |
| 04/29/2014 | US8709385 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| 04/29/2014 | US8709342 Antimicrobial flush solutions |
| 04/29/2014 | US8708944 System for harvesting and dispensing a fibrin clot |
| 04/29/2014 | CA2791389C Amino -dihydrooxazine and amino - dihydrothiazine spiro compounds as beta - secretase modulators and their medical use |
| 04/29/2014 | CA2789115C Microporation of tissue for delivery of bioactive agents |
| 04/29/2014 | CA2777018C Novel method for preparing entecavir and intermediate used therein |
| 04/29/2014 | CA2775393C Topical non-aqueous pharmaceutical formulations |
| 04/29/2014 | CA2753552C N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators |
| 04/29/2014 | CA2746769C Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals |
| 04/29/2014 | CA2734877C [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase |
| 04/29/2014 | CA2734677C 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases |
| 04/29/2014 | CA2721007C Derivatives of galantamine as pro-drugs for the treatment of human brain diseases |
| 04/29/2014 | CA2704778C Formulations for enhanced bioavailability of orally administered polar agents |
| 04/29/2014 | CA2693406C Compounds and methods for modulating fxr |
| 04/29/2014 | CA2681206C 8-(heteroarylmethoxy)quinoline compounds as bradykinin b2 receptor modulators |
| 04/29/2014 | CA2669266C Pyridinone compounds |
| 04/29/2014 | CA2664126C The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 04/29/2014 | CA2655573C Therapeutic or prophylactic agent for multiple sclerosis |
| 04/29/2014 | CA2651153C Antidiabetic bicyclic compounds |
| 04/29/2014 | CA2645629C Orodispersible domperidone tablets |
| 04/29/2014 | CA2643714C Aryl/alkyl vinyl sulfone hyaluronic acid derivatives |
| 04/29/2014 | CA2637631C Pyrimidine compounds and uses thereof |
| 04/29/2014 | CA2635379C Hemostatic material |
| 04/29/2014 | CA2635124C Novel pyridine derivatives |
| 04/29/2014 | CA2632635C Novel inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 04/29/2014 | CA2631931C Cancer therapies and pharmaceutical compositions used therein |
| 04/29/2014 | CA2619284C Novel crystalline form of a pyridazino [4,5-b] indole derivative |
| 04/29/2014 | CA2615938C Urea glucokinase activators |
| 04/29/2014 | CA2609456C Localized delivery of cardiac inotropic agents |
| 04/29/2014 | CA2609224C Derivatives of 4-or 5-aminosalicylic acid |
| 04/29/2014 | CA2602075C N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
| 04/29/2014 | CA2597350C Process for purifying noroxymorphone compounds |
| 04/29/2014 | CA2594203C Use of a vanilloid receptor agonist together with a glycosaminoglycan or proteoglycan for producing an agent for treating articular pain and method for applying said agent |
| 04/29/2014 | CA2591438C Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 04/29/2014 | CA2589085C Cathepsin cysteine protease inhibitors |
| 04/29/2014 | CA2585976C Novel composition for easing human childbirth |
| 04/29/2014 | CA2573976C Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/29/2014 | CA2570873C Pyrimidine urea derivatives as kinase inhibitors |
| 04/29/2014 | CA2554809C Novel n-alkyl thiourea-and thioamide-substituted imidazolyl inhibitors and glutaminyl cyclase |
| 04/29/2014 | CA2551567C Propofol analogs, process for their preparation, and methods of use |
| 04/29/2014 | CA2550361C Compounds and methods for development of ret modulators |
| 04/29/2014 | CA2542942C Nucleic acids useful for triggering tumor cell lethality |
| 04/29/2014 | CA2524009C Use of effectors of glutaminyl and glutamate cyclases |
| 04/29/2014 | CA2522739C Pharmaceutical compositions comprising cereal beta (1-3) beta (1-4) glucan |
| 04/29/2014 | CA2516078C Catechol compositions and use thereof |
| 04/29/2014 | CA2408571C Mammalian receptor proteins; related reagents and methods |
| 04/29/2014 | CA2232048C Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 04/24/2014 | WO2014063168A1 Heterocycle-bisamide inhibitors of scavenger receptor bl |